ClassID:

95251

C07D403/10 - page 6 - CPC Classification

Classification description:

Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a carbon chain containing aromatic rings

Recent Application in this class:
#1501
20130306955
2013-11-21

Nitrogenated heterocyclic derivative, electron-transporting material for organic electroluminescent elements, and organic electroluminescent element using same

#1502
20130303493
2013-11-14

Triazole compounds that modulate HSP90 activity

#1503
20130302378
2013-11-14

Matrix metalloproteinase inhibitors

#1504
20130289085
2013-10-31

Histone deacetylase (HDAC) inhibitors targeting prostate tumors and methods of making and using thereof

#1505
20130289003
2013-10-31

Diazeniumdiolate heterocyclic derivatives

#1506
20130281450
2013-10-24

Isoindolone derivatives

#1507
20130281441
2013-10-24

Diazepinedione derivative

#1508
20130281431
2013-10-24

DNA-PK inhibitors

#1509
20130281426
2013-10-24

Substituted pyridazinones for the treatment of tumors

#1510
20130281399
2013-10-24

TREATMENT OF DISEASES BY EPIGENETIC REGULATION

#1511
20130281385
2013-10-24

Small molecule apoptosis promoters

#1512
20130270524
2013-10-17

Compound for organic light-emitting diode and organic light-emitting diode including the same

#1513
20130267711
2013-10-10

TRICYCLIC COMPOUND

#1514
20130267539
2013-10-10

Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents

#1515
20130267532
2013-10-10

CYCLIC AMIDE COMPOUNDS AND THEIR USE IN THE TREATMENT OF DISEASE

#1516
20130267491
2013-10-10

Pyrimidine compounds as inhibitors of protein kinases IKK epsilon and/or TBK-1, processes for their preparation, and pharmaceutical compositions containing them

#1517
20130261128
2013-10-03

Continuous arycyclic compound

#1518
20130261123
2013-10-03

Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors

#1519
20130261122
2013-10-03

Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors

#1520
20130261118
2013-10-03

Compounds for Alzheimer's disease

#1521
20130261081
2013-10-03

Substituted quinoxalines compounds

#1522
20130256641
2013-10-03

Benzimidazole compound, organic photoelectric device including the same, and display element including the same

#1523
20130245041
2013-09-19

Dual-acting pyrazole antihypertensive agents

#1524
20130240796
2013-09-19

Materials for organic electroluminescent devices

#1525
20130237575
2013-09-12

Anti-infective agents against intracellular pathogens

#1526
20130237515
2013-09-12

Pyridone and pyridazinone derivatives as anti-obesity agents

#1527
20130234119
2013-09-12

Material for organic electroluminescence device and organic electroluminescence device

#1528
20130231333
2013-09-05

Estrogen receptor modulators and uses thereof

#1529
20130225831
2013-08-29

Radio-methyl vorozole and methods for making and using the same

#1530
20130225580
2013-08-29

Aza-aryl 1H-pyrazol-1-YL benzene sulfonamides

#1531
20130217709
2013-08-22

Cyclic amine azaheterocyclic carboxamides

#1532
20130217680
2013-08-22

Inhibitors of the renal outer medullary potassium channel

#1533
20130217669
2013-08-22

Azetidinyl diamides as monoacylglycerol lipase inhibitors

#1534
20130214258
2013-08-22

Carbazole compound, material for organic electroluminescence device and organic electroluminescence device

#1535
20130210874
2013-08-15

Dual-acting antihypertensive agents

#1536
20130210805
2013-08-15

Quinazolinone-type compounds as CRTH antagonists

#1537
20130202573
2013-08-08

Thioacetate compounds, compositions and methods of use

#1538
20130200356
2013-08-08

Compound for organic optoelectronic device, organic light emitting diode including the same and display including the organic light emitting diode

#1539
20130197217
2013-08-01

1, 2, 4-triazolone derivative and use thereof as an antagonist on the arginine-vasopressin 1B receptor

#1540
20130196990
2013-08-01

Benzimidazole Derivatives As PI3 Kinase Inhibitors

#1541
20130196967
2013-08-01

Heterocyclic compounds as inhibitors of leukotriene production

#1542
20130196002
2013-08-01

Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders

#1543
20130190311
2013-07-25

Pyridazinone derivatives

#1544
20130188270
2013-07-25

Oxime ester

#1545
20130184459
2013-07-18

P2Xreceptor antagonist

#1546
20130184261
2013-07-18

Pyridazinone derivatives

#1547
20130184260
2013-07-18

Pyridazinone derivatives

#1548
20130178625
2013-07-11

P 2×4 receptor antagonist

#1549
20130178507
2013-07-11

Substituted bicyclic HCV inhibitors

#1550
20130175509
2013-07-11

Condensed-cyclic compound and organic light emitting diode including the same

#1551
20130172570
2013-07-04

METHOD OF MAKING BENZAZOLES

#1552
20130172550
2013-07-04

P2Xreceptor antagonist

#1553
20130172352
2013-07-04

5-membered heterocycle-based p38 kinase inhibitors

#1554
20130172351
2013-07-04

Dihydropyrazoles

#1555
20130165440
2013-06-27

JAK1 Inhibitors

#1556
20130158041
2013-06-20

Tyrosine Kinase Inhibitors

#1557
20130150374
2013-06-13

Arylalkylamine compound and process for preparing the same

#1558
20130150368
2013-06-13

Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use

#1559
20130150350
2013-06-13

Derivatives of 1-Phenyl-1,5-Dihydro-Benzo[B] [1,4]Diazepine-2,4-Dione as Inhibitors of HIV Replication

#1560
20130150325
2013-06-13

3-(Fluorovinyl)pyrazoles and their use

#1561
20130146856
2013-06-13

Compounds for use in light-emitting devices

#1562
20130143880
2013-06-06

Positive allosteric modulators of MGLUR2

#1563
20130137740
2013-05-30

Combretastatin analogs for use in the treatment of cancer

#1564
20130126856
2013-05-23

Compound having indenocarbazole ring structure, and organic electroluminescent device

#1565
20130123493
2013-05-16

Process for the synthesis of substituted urea compounds

#1566
20130123297
2013-05-16

Pharmaceutical composition for preventing or treating osteoporosis or obesity comprising phenyltetrazole derivative

#1567
20130123289
2013-05-16

Certain amino-pyrimidines, compositions thereof, and methods for their use

#1568
20130123257
2013-05-16

Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes

#1569
20130123230
2013-05-16

2-thiopyrimidinones

#1570
20130116230
2013-05-09

3-aminopyrrolidine derivatives as modulators of chemokine receptors

#1571
20130115193
2013-05-09

Hepatitis C Virus Inhibitors

#1572
20130102618
2013-04-25

3-AMINO-5,6-DIHYDRO-1H-PYRAZIN-2-ONE DERIVATIVES USEFUL FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER FORMS OF DEMENTIA

#1573
20130102604
2013-04-25

NOVEL CYCLOPROPANE INDOLINONE DERIVATIVES

#1574
20130096301
2013-04-18

Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-ones

#1575
20130096145
2013-04-18

Use of 1H-quinazoline-2,4-diones

#1576
20130095035
2013-04-18

Polyanionic multivalent macromolecules for intracellular targeting of proliferation and protein synthesis

#1577
20130090346
2013-04-11

Use of 1H-quinazoline-2,4-diones

#1578
20130090342
2013-04-11

BIPHENYL SUBSTITUTED 1,3-DIHYDRO-BENZOIMIDAZOL-2-YLIDENEAMINE DERIVATIVES

#1579
20130087768
2013-04-11

Heterocyclic compound, organic light-emitting diode comprising the heterocyclic compound, and flat panel display device comprising the organic light-emitting diode

#1580
20130085135
2013-04-04

5H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitors

#1581
20130079517
2013-03-28

Electroluminescent Device

#1582
20130079349
2013-03-28

5-AMINO-3,6-DIHYDRO-1H-PYRAZIN-2-ONE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE)

#1583
20130072468
2013-03-21

SUBSTITUTED PIPERAZINES AS CB1 ANTAGONISTS

#1584
20130072461
2013-03-21

TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY

#1585
20130065897
2013-03-14

COMPOUNDS, PREPARATION AND USES THEREOF

#1586
20130065877
2013-03-14

Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof

#1587
20130060033
2013-03-07

LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE, LIGHTING DEVICE, AND HETEROCYCLIC COMPOUND

#1588
20130059874
2013-03-07

SUBSTITUTED N-PHENYL SPIROLACTAM BIPYRROLIDINES, PREPARATION AND THERAPEUTIC USE THEREOF

#1589
20130053576
2013-02-28

Heterogeneous rhodium metal catalysts

#1590
20130053558
2013-02-28

Organic compounds for electroluminescent devices

#1591
20130053372
2013-02-28

5-HT RECEPTOR MODULATORS

#1592
20130048955
2013-02-28

Heterocyclic compound and organic light-emitting device containing the same

#1593
20130045955
2013-02-21

Pyrimidline derivatives having immune modulating properties that act via TLR7 for the treatment of viral or allergic diseases and cancers

#1594
20130045914
2013-02-21

Biaryl spiroaminooxazoline analogues as Alpha2C adrenergic receptor modulators

#1595
20130040931
2013-02-14

Amino heteroaryl compounds as beta-secretase modulators and methods of use

#1596
20130032786
2013-02-07

ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE EMPLOYING THE SAME

#1597
20130025684
2013-01-31

Organic electronic devices using phthalimide compounds

#1598
20130023539
2013-01-24

Substituted pyrrolidines as G-protein coupled receptor 43 agonists

#1599
20130020565
2013-01-24

Material for organic electroluminescent element, and organic electroluminescent element using same

#1600
20130020563
2013-01-24

POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME

#1601
20130018066
2013-01-17

Heterocyclic aspartyl protease inhibitors

#1602
20130012561
2013-01-10

Estrogen receptor modulators and uses thereof

#1603
20130012540
2013-01-10

Hepatitis C virus inhibitors

#1604
20130012491
2013-01-10

PYRIMIDINE DERIVATIVES FOR USE AS SPHINGOSINE 1-PHOSPHATE 1 (S1P1) RECEPTOR AGONISTS

#1605
20130012485
2013-01-10

ORGANIC COMPOUNDS

#1606
20130011952
2013-01-10

Method for producing organic electroluminescence element

#1607
20130005963
2013-01-03

ORGANIC PHOTOELECTRIC CONVERSION MATERIAL AND ORGANIC THIN-FILM PHOTOELECTRIC CONVERSION DEVICE

#1608
20130005702
2013-01-03

Pyrazole derivatives as protein kinase modulators

#1609
20120330026
2012-12-27

Process for the preparation of tetrazole derivatives from organo boron and organo aluminium azides

#1610
20120330020
2012-12-27

Method for preparing tetrazole methanesulfonic acid salts, and novel compound used in same

#1611
20120330009
2012-12-27

Triazole compounds that modulate Hsp90 activity

#1612
20120329794
2012-12-27

Ab1 KINASE INHIBITORS

#1613
20120328975
2012-12-27

Perimidine-based squarylium dye, dye-containing composition, and image-forming material

#1614
20120319099
2012-12-20

Material for organic electroluminescence devices and organic electroluminescence device using the material

#1615
20120319095
2012-12-20

Organic electroluminescent device

#1616
20120319086
2012-12-20

Condensed-cyclic compound and organic light-emitting diode comprising the same

#1617
20120316201
2012-12-13

NOVEL BENZIMIDAZOLE AND IMIDAZOPYRIDINE DERIVATIVES AND USE THEREOF AS A MEDICAMENT

#1618
20120313506
2012-12-13

Quinoxaline Derivative, and Light-Emitting Device, Electronic Device Using the Quinoxaline Derivative

#1619
20120309984
2012-12-06

Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative

#1620
20120309757
2012-12-06

N-biphenylmethylindole modulators of PPARG

#1621
20120306362
2012-12-06

Material for organic electroluminescence device and organic electroluminescence device

#1622
20120302617
2012-11-29

Phenyl and benzodioxinyl substituted indazoles derivatives

#1623
20120298975
2012-11-29

MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICES AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE MATERIAL

#1624
20120295908
2012-11-22

Pyrimidinyl pyridazinone derivatives

#1625
20120295904
2012-11-22

Hematopoietic growth factor mimetic small molecule compounds and their uses

#1626
20120295901
2012-11-22

Substituted bicyclic triazole derivatives as gamma secretase modulators

#1627
20120295891
2012-11-22

Substituted triazole derivatives as gamma secretase modulators

#1628
20120295885
2012-11-22

Inhibitors of bruton's tyrosine kinase

#1629
20120289471
2012-11-15

NOVEL COMPOUNDS WITH HIGH THERAPEUTIC INDEX

#1630
20120283287
2012-11-08

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

#1631
20120280218
2012-11-08

ORGANIC ELECTROLUMINESCENCE DEVICE

#1632
20120276651
2012-11-01

Fluorescent nanoprobe for detecting hydrogen peroxide and fabrication method thereof

#1633
20120270867
2012-10-25

(6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives, preparation thereof and pharmaceutical use thereof as AKT(PKB) phosphorylation inhibitors

#1634
20120270862
2012-10-25

1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties

#1635
20120264801
2012-10-18

5-membered heterocycle-based P38 kinase inhibitors

#1636
20120264800
2012-10-18

Kinase inhibitors and method of treating cancer

#1637
20120264754
2012-10-18

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

#1638
20120264753
2012-10-18

NOVEL 1-(BIPHENYL-4-YL-METHYL)-1H-IMIDAZOLE DERIVATIVE AND PHARMACEUTICAL PRODUCT CONTAINING SAME

#1639
20120264752
2012-10-18

Dual-acting antihypertensive agents

#1640
20120264735
2012-10-18

TYROSINE KINASE INHIBITORS

#1641
20120259113
2012-10-11

Dual-acting pyrazole antihypertensive agents

#1642
20120245147
2012-09-27

INHIBITORS OF THAPSIGARGIN-INDUCED CELL DEATH

#1643
20120244119
2012-09-27

Anti-infective agents and uses thereof

#1644
20120238611
2012-09-20

Dual-acting benzoimidazole antihypertensive agents

#1645
20120238608
2012-09-20

Angiotensin II receptor antagonists

#1646
20120232283
2012-09-13

Process for production of biphenyl derivative

#1647
20120232278
2012-09-13

Insecticidal aryl pyrrolidines

#1648
20120232070
2012-09-13

Use of Indole Derivatives as Nurr-1 Activators for the Application Thereof as a Medicament for the Treatment of Parkinson's Disease

#1649
20120232063
2012-09-13

2-aminoindole compounds and methods for the treatment of malaria

#1650
20120232039
2012-09-13

Primary amine diazeniumdiolate heterocyclic derivatives

#1651
20120228554
2012-09-13

Materials for organic electroluminescent devices

#1652
20120228552
2012-09-13

Materials for organic electroluminescent devices

#1653
20120225873
2012-09-06

Compounds for Alzheimer's disease

#1654
20120223276
2012-09-06

Materials for electronic devices

#1655
20120220622
2012-08-30

Heterocyclic derivatives

#1656
20120217483
2012-08-30

Quinone compounds as dopants in organic electronics

#1657
20120217449
2012-08-30

MATERIALS FOR ELECTRONIC DEVICES

#1658
20120214993
2012-08-23

Cyclic azine derivatives, processes for producing these, and organic electroluminescent element containing these as component

#1659
20120214849
2012-08-23

Dual-acting antihypertensive agents

#1660
20120214801
2012-08-23

COMPOSITIONS AND METHODS RELATING TO NOVEL COMPOUNDS AND TARGETS THEREOF

#1661
20120214789
2012-08-23

Tetrazole-substituted arylamides as P2Xand P2Xantagonists

#1662
20120213733
2012-08-23

Anti-infective agents and uses thereof

#1663
20120208817
2012-08-16

Dihydropyrimidin-2(1H)-one compounds as S-nitrosoglutathione reductase inhibitors

#1664
20120202816
2012-08-09

Pyrazole-based thyroid receptor compounds

#1665
20120202813
2012-08-09

Triazole compounds that modulate HSP90 activity

#1666
20120199818
2012-08-09

Triazole derivative, and light-emitting element, light-emitting device, and electronic device with the use of triazole derivative

#1667
20120197179
2012-08-02

Phototherapy devices and methods comprising optionally substituted terphenyl and quaterphenyl compounds

#1668
20120197020
2012-08-02

Heterocyclic compound

#1669
20120196859
2012-08-02

Heterocyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase

#1670
20120193613
2012-08-02

Heterocyclic compound

#1671
20120190700
2012-07-26

4-amino-N-hydroxy-benzamides for the treatment of cancer

#1672
20120190668
2012-07-26

ENHANCEMENT OF CELLULAR TRANSPLANTATION USING SMALL MOLEUCLE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY

#1673
20120189580
2012-07-26

Anti-infective agents and uses thereof

#1674
20120184583
2012-07-19

MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS

#1675
20120165381
2012-06-28

Dual-acting imidazole antihypertensive agents

#1676
20120157432
2012-06-21

Pyrrolidine derived beta 3 adrenergic receptor agonists

#1677
20120157414
2012-06-21

Cannabinoid receptor antagonists-inverse agonists useful for treating metabolic disorders, including obesity and diabetes

#1678
20120149904
2012-06-14

Bispyrimidines for electronic applications

#1679
20120136006
2012-05-31

Cold menthol receptor antagonists

#1680
20120135997
2012-05-31

PHARMACEUTICAL COMPOSITION COMPRISING A LACTAM OR BENZENESULFONAMIDE COMPOUND

#1681
20120135981
2012-05-31

Substituted triazole and imidazole derivatives as gamma secretase modulators

#1682
20120132899
2012-05-31

Nitrogenated heterocyclic ring derivative and organic electroluminescent element comprising same

#1683
20120126221
2012-05-24

CHARGE-TRANSPORTING MATERIAL AND ORGANIC ELECTROLUMINESCENCE DEVICE

#1684
20120126217
2012-05-24

Fluorene-containing aromatic compound, material for organic electroluminescent element, and organic electroluminescent element using same

#1685
20120126179
2012-05-24

Materials for organic electroluminescent devices

#1686
20120122869
2012-05-17

Triazole compounds that modulate HSP90 activity

#1687
20120122842
2012-05-17

NAMPT and rock inhibitors

#1688
20120116093
2012-05-10

One pot process for preparing 2-butyl-3-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1,3-diazaspiro [4, 4] non-1-en-4-one (irbesartan)

#1689
20120116075
2012-05-10

Acrylamide derivative and use thereof in manufacture of medicament

#1690
20120115844
2012-05-10

Triazole compounds I

#1691
20120114696
2012-05-10

Small-molecule botulinum toxin inhibitors

#1692
20120112629
2012-05-10

Crosslinked pi-conjugated heteroacene compound for organic electroluminescence device and organic electroluminescence device using the same

#1693
20120108635
2012-05-03

Insecticidal arylpyrrolines

#1694
20120108602
2012-05-03

Carbamoyl Compounds as DGAT1 Inhibitors 190

#1695
20120104379
2012-05-03

Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative

#1696
20120101099
2012-04-26

HISTONE DEACETYLASE INHIBITORS

#1697
20120101072
2012-04-26

Triazole compounds that modulate Hsp90 activity

#1698
20120101064
2012-04-26

Imidazole derivatives and their use as modulators of cyclin dependent kinases

#1699
20120097929
2012-04-26

Heterocyclic compound and organic light-emitting device including the same

#1700
20120095047
2012-04-19

Heteropyrrole analogs acting on cannabinoid receptors

#1701
20120095038
2012-04-19

Synthesis and anti-proliferative effect of substituted imidazo[4,5-c]pyridine compounds

#1702
20120095037
2012-04-19

Synthesis and anti-proliferative effect of substituted imidazo[4,5-]pyridine compounds

#1703
20120095027
2012-04-19

Synthesis and anti-proliferative effect of benzimidazole derivatives

#1704
20120095009
2012-04-19

Synthesis and anti-proliferative effect of substituted imidazo[4,5-b]pyrazine compounds

#1705
20120091450
2012-04-19

Organic compound and organic light-emitting device

#1706
20120088788
2012-04-12

Substituted imidazoles as bombesin receptor subtype-3 modulators

#1707
20120088767
2012-04-12

Benzimidazole derivatives as P13 kinase inhibitors

#1708
20120088758
2012-04-12

Five-membered heterocycles useful as serine protease inhibitors

#1709
20120085995
2012-04-12

Crosslinked pi-conjugated heteroacene compound for organic electroluminescence device and organic electroluminescence device using the same

#1710
20120082646
2012-04-05

Antiviral compounds and uses thereof

#1711
20120082640
2012-04-05

Small molecule apoptosis promoters

#1712
20120071651
2012-03-22

Processes for preparing 1,2-substituted cyclopropyl derivatives

#1713
20120071535
2012-03-22

Estrogen receptor modulators and uses thereof

#1714
20120068170
2012-03-22

Materials for organic electroluminescent devices

#1715
20120065195
2012-03-15

COMPOUNDS FOR TREATING NEURODEGENERATIVE DISEASES

#1716
20120059172
2012-03-08

Acetone solvate crystals of trityl olmesartan medoxomil

#1717
20120058996
2012-03-08

Carbazole carboxamide compounds useful as kinase inhibitors

#1718
20120046327
2012-02-23

METHOD FOR INHIBITING THE INDUCTION AND FORMATION OF OSTEOCLASTS

#1719
20120046300
2012-02-23

Quinazoline Derivatives as Angiogenesis Inhibitors

#1720
20120040960
2012-02-16

4-Azetidinyl-1-phenyl-cyclohexane antagonists of CCR2

#1721
20120040954
2012-02-16

Anti-inflammatory agents

#1722
20120038264
2012-02-16

Carbazole derivatives and organic light-emitting diode device using the same

#1723
20120029201
2012-02-02

PROCESS FOR THE PREPARATION OF CANDESARTAN CILEXETIL

#1724
20120022118
2012-01-26

Compounds for the treatment of proliferative disorders

#1725
20120010204
2012-01-12

Phthalazinone derivatives

#1726
20120010185
2012-01-12

NEW PYRIDONE DERIVATES WITH MCH ANTAGONISTIC ACTIVITY AND MEDICAMENTS COMPRISING THESE COMPOUNDS

#1727
20120004259
2012-01-05

Method of treatment or prophylaxis

#1728
20110319614
2011-12-29

Organic Compounds

#1729
20110319610
2011-12-29

Diazepinedione derivative

#1730
20110319426
2011-12-29

Substituted Isoindoles

#1731
20110318329
2011-12-29

Method of treatment or prophylaxis

#1732
20110313001
2011-12-22

TRIAZOLE DERIVATIVES FOR TREATMENT OF ALZHEIMER'S DISEASE

#1733
20110309348
2011-12-22

Organic light-emitting device

#1734
20110306603
2011-12-15

Large substituent, non-phenolic opioids and methods of use thereof

#1735
20110300103
2011-12-08

Quinoline inhibitors of hepatitis C virus polymerase

#1736
20110297919
2011-12-08

Organic light-emitting device

#1737
20110285276
2011-11-24

Triazole derivative, and light-emitting element, light-emitting device, electronic device and lighting device using the triazole derivative

#1738
20110281925
2011-11-17

Dual-acting antihypertensive agents

#1739
20110281910
2011-11-17

Hepatitis C Virus Inhibitors

#1740
20110281881
2011-11-17

Substituted bicyclic heterocyclic compounds as gamma secretase modulators

#1741
20110278552
2011-11-17

Material for organic electroluminescent device and organic electroluminescent device using same

#1742
20110275828
2011-11-10

Process for the preparation of irbesartan

#1743
20110275814
2011-11-10

Material for organic electroluminescence device and organic electroluminescence device

#1744
20110275634
2011-11-10

Dual-acting pyrazole antihypertensive agents

#1745
20110274648
2011-11-10

Hepatitis C Virus Inhibitors

#1746
20110272680
2011-11-10

Organic electroluminescent device having triptycene derivative material

#1747
20110272676
2011-11-10

BENZIMIDAZOLE COMPOUND ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME, AND DISPLAY ELEMENT INCLUDING THE SAME

#1748
20110269806
2011-11-03

2-(2-hydroxybiphenyl-3-yl)-1-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors

#1749
20110269767
2011-11-03

Polymorphic forms of 3-(1-{3-[5-(1-methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile hydrochloride salt and processes of manufacturing thereof

#1750
20110269765
2011-11-03

Pyridazinone derivatives

#1751
20110263598
2011-10-27

Kinase inhibitors and method of treating cancer

#1752
20110263565
2011-10-27

Compounds

#1753
20110263559
2011-10-27

Indazole compounds useful as ketohexokinase inhibitors

#1754
20110263543
2011-10-27

Anti inflammatory compounds

#1755
20110263526
2011-10-27

Nitric Oxide Releasing Prodrugs of Therapeutic Agents

#1756
20110260153
2011-10-27

COMPOUND FOR ORGANIC PHOTOELECTRIC DEVICE, ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING THE SAME

#1757
20110257210
2011-10-20

BENZIMIDAZOLE DERIVATIVES AND THEIR USE FOR MODULATING THE GABAA RECEPTOR COMPLEX

#1758
20110257178
2011-10-20

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

#1759
20110251401
2011-10-13

Polyphenylene host compounds

#1760
20110251207
2011-10-13

Biaryl-spiroaminooxazoline analogues as alpha 2C adrenergic receptor modulators

#1761
20110251181
2011-10-13

5H-cyclopenta[D]pyrimidines as AKT protein kinase inhibitors

#1762
20110251168
2011-10-13

3-aminopyrrolidine derivatives as modulators of chemokine receptors

#1763
20110248257
2011-10-13

Compound for an organic photoelectric device, organic photoelectric device, and display device including the same

#1764
20110240978
2011-10-06

Heterocyclic compound and organic light-emitting device including the same

#1765
20110230525
2011-09-22

Dual-acting antihypertensive agents

#1766
20110218194
2011-09-08

Heterocyclic aspartyl protease inhibitors

#1767
20110218160
2011-09-08

Arylalkylamine compound and process for preparing the same

#1768
20110212940
2011-09-01

S1P Receptor Modulating Compounds and Use Thereof

#1769
20110212925
2011-09-01

Compounds as receptor modulators with therapeutic utility

#1770
20110210318
2011-09-01

Material for organic electronic device, and organic electronic device using same

#1771
20110210316
2011-09-01

Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device

#1772
20110207715
2011-08-25

Disubstituted azepan orexin receptor antagonists

#1773
20110201657
2011-08-18

AMIDE SUBSTITUTED INDAZOLE AND BENZOTRIAZOLE DERIVATIVES AS POLY(ADP-RIBOSE)POLYMERASE (PARP) INHIBITORS

#1774
20110201640
2011-08-18

Tricyclic compound

#1775
20110201621
2011-08-18

Angiotensin II receptor antagonists

#1776
20110198574
2011-08-18

Quinoxaline derivative, and light-emitting device, electronic device using the quinoxaline derivative

#1777
20110195964
2011-08-11

Cyclic benzimidazole derivatives useful as anti-diabetic agents

#1778
20110190365
2011-08-04

Insecticidal 4-phenyl-1H-pyrazoles

#1779
20110190343
2011-08-04

HIV-1 fusion inhibitors and methods

#1780
20110184187
2011-07-28

PROCESS FOR THE PREPARATION OF TETRAZOLE DERIVATIVES FROM ORGANO BORON AND ORGANO ALUMINIUM AZIDES

#1781
20110178101
2011-07-21

Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents

#1782
20110178060
2011-07-21

Nitrogen-containing heterocyclic compound and use of same

#1783
20110172439
2011-07-14

Chromophores, method for the preparation thereof, and use of same

#1784
20110152533
2011-06-23

Prodrugs of inhibitors of plasma kallikrein

#1785
20110152278
2011-06-23

Synthesis and anti-proliferative effect of benzimidazole derivatives

#1786
20110152241
2011-06-23

Compounds as receptor modulators with therapeutic utility

#1787
20110144331
2011-06-16

Cinnoline Compounds for the Treatment of Anxiety, Cognitive and Mood Disorders

#1788
20110144180
2011-06-16

Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents

#1789
20110144110
2011-06-16

Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents

#1790
20110144106
2011-06-16

Cyclopropane indolinone derivatives

#1791
20110144105
2011-06-16

Azaindole glucokinase activators

#1792
20110144080
2011-06-16

Pyrazole derivatives as protein kinase modulators

#1793
20110140093
2011-06-16

Compounds for use in light-emitting devices

#1794
20110136875
2011-06-09

Pyrrole inhibitors of S-nitrosoglutathione reductase

#1795
20110136819
2011-06-09

6-THIOXOPYRIDAZINE DERIVATIVES

#1796
20110136813
2011-06-09

Wnt protein signalling inhibitors

#1797
20110135604
2011-06-09

Antiviral compounds

#1798
20110135600
2011-06-09

Bicyclic traizole derivatives for treating of tumors

#1799
20110130433
2011-06-02

Hepatitis C virus inhibitors

#1800
20110124585
2011-05-26

Dimeric small molecule potentiators of apoptosis